https://doi.org/10.1016/s0140-6736(21)00149-5
A
Angela Aramburo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
1.8K
Citations
15
h-index
16
i10-index
Angela Aramburo is an academic researcher from Royal Brompton & Harefield NHS Foundation Trust. The author has contributed to research in topics: Respiratory Support and Mechanisms & Cardiac Arrest and Resuscitation & Pneumonia and Respiratory Infections. The author has an h-index of 15, co-authored 25 publications.
ORCID: 0000-0002-2521-3550Papers by this author
worksAzithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 556 citations
INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia
2025 · Intensive Care Medicine · 30 citations
https://doi.org/10.1007/s00134-024-07772-2
Imaging of cerebral complications of extracorporeal membrane oxygenation in infants with congenital heart disease — ultrasound with multimodality correlation
2020 · Pediatric Radiology · 10 citations
https://doi.org/10.1007/s00247-019-04603-1
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · The Lancet Infectious Diseases · 0 citations
https://doi.org/10.1016/s1473-3099(25)00361-5
Correction: Cost-effectiveness of rapid, ICU-based, syndromic PCR in hospital-acquired pneumonia: analysis of the INHALE WP3 multi-centre RCT
2025 · Critical Care · 0 citations
https://doi.org/10.1186/s13054-025-05645-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat